FDA approves Advair Diskus debut sugo
-
Last Update: 2020-06-10
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
asthma is a chronic lung disease in which the airways of patients develop inflammation and narrow, leading to repeated chest tightness, shortness of breath, cough and other symptomstoday, theFDA(http://announced that it has approved the first genericPharmaceutical(http://for the use of the first generic pharmaceutical(http://for treatment of asthma patients over the age of 4 twice a day, as a maintenance therapy for chronic obstructive pulmonary disease (COPD) airway blockages and worsening diseaseThe first drug was developed by Mylan(http://schurideOne of the most common prescription drugs for asthma and COPD in the United States, it consists of two active ingredients, sametero and fluoroteocasineSametero is a long-acting beta 2 epinephrine receptor agonist that acts as a long-lasting expansion of bronchialFluoritasine fluorocoacid can produce powerful glucocorticoids in the lungs to fight inflammation, thereby reducing asthma symptoms and preventing the disease from worseningthis treatment is a combination of drug (http:// ) -
device (http:// product
(http:// product, which consists of drugs and inhalers This combination is more difficult to replicate than oral tablets
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
